Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 8/20 | 0.41 |
| ▸ | METAP1 | P53582 | 2/20 | 0.39 |
| ▸ | LAP3 | P28838 | 4/20 | 0.36 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 2/20 | 0.33 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2779238 | 0.90 | — | — | |
| SCHEMBL5005860 | 0.76 | — | — | |
| Butane SCHEMBL7716695 | 0.74 | FDPS (0.39) | FDPSMETAP1LAP3LPAR3LPAR2 | |
| Butane SCHEMBL7715863 | 0.73 | FDPS (0.38) | FDPSMETAP1LAP3LPAR3LPAR2 | |
| Butane SCHEMBL7714644 | 0.73 | FDPS (0.48) | FDPSMETAP1LAP3 | |
| SCHEMBL20606630 | 0.72 | TSHR (0.35) | LAP3 | |
| SCHEMBL11793622 | 0.71 | ACHE (0.39) | — | |
| Phosphoric Acid SCHEMBL5804818 | 0.71 | FDPS (0.38) | FDPSMETAP1LPAR3LPAR2 | |
| Butane SCHEMBL6817226 | 0.71 | FDPS (0.38) | FDPSMETAP1LPAR3LPAR2 | |
| SCHEMBL11891895 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6376512-B1 | FOR TREATING PHYSIOLOGICAL CONDITION IN PATIENT WHEREIN SAID CONDITION IS ASSOCIATED WITH A PHYSIOLOGICALLY DETRIMENTAL LEVELS OF INSULIN, GLUCOSE, FREE FATTY ACIDS, OR TRIGLYCERIDES | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-04-23 | — | — | US | disclosed |
| EP-0315399-B1 | Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same | RHONE POULENC RORER INT (US) | 1996-01-10 | — | — | EP | disclosed |
| US-5059610-A | QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-10-22 | — | — | US | disclosed |
| US-4920132-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |